Descovy Archives -

Gilead has won a crucial court order in a wide-ranging lawsuit against a network of clinics, prescribers, medical

Gilead wins court order against fraudsters targeting HIV programme

https://pharmaphorum.com/news/gilead-wins-court-order-against-fraudsters-targeting-hiv-programme/

US pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than

Gilead takes legal action against counterfeit HIV drug network

https://pharmaphorum.com/news/gilead-takes-legal-action-against-counterfeit-hiv-drug-network/

GlaxoSmithKline’ majority-owned HIV unit ViiV has scored a key FDA approval, getting approval for its long-acting drug cabotegravir

FDA okays ViiV’s Apretude as first injectable for HIV PrEP

https://pharmaphorum.com/news/fda-okays-viivs-apretude-as-first-injectable-for-hiv-prep/

Gilead’s Descovy got a green light from an FDA advisory committee for HIV pre-exposure prophylaxis (PrEP) yesterday –

Gilead’s Descovy gets FDA panel OK for PrEP, but not for women

https://pharmaphorum.com/news/gileads-descovy-gets-fda-panel-ok-for-prep-but-not-for-women/

Gilead Sciences’ Descovy, its successor to HIV pre-exposure prophylaxis (PrEP) therapy Truvada, is heading into an FDA advisory

FDA reviewer backs Gilead’s Descovy for PrEP, but not in women

https://pharmaphorum.com/news/fda-reviewer-backs-gileads-descovy-for-prep-but-not-in-women/

Gilead Sciences has filed Descovy, its successor to HIV pre-exposure prophylaxis (PrEP) therapy Truvada, in the US, spending

Gilead files Truvada follow-up Descovy for PrEP

https://pharmaphorum.com/news/gilead-files-truvada-follow-up-descovy-for-prep/

Descovy